triazoles has been researched along with veliparib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, L; Gu, Y; Jiang, J; Li, L; Li, Z; Liu, J; Lu, Y; Niu, D; Xia, F; Xu, W; Zhou, Z | 1 |
1 other study(ies) available for triazoles and veliparib
Article | Year |
---|---|
Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; DNA Repair; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; HSP90 Heat-Shock Proteins; Humans; Mammary Neoplasms, Experimental; Mice, SCID; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase; Radiation, Ionizing; Triazoles; Tumor Burden | 2017 |